Back to top
more

Acorda Therapeutics, Inc. (ACOR)

(Delayed Data from NSDQ)

$11.74 USD

11.74
1,452,260

+1.16 (10.96%)

Updated May 3, 2019 04:00 PM ET

After-Market: $11.74 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[ACOR]

Reports for Purchase

Showing records 141 - 160 ( 440 total )

Industry: Medical - Biomedical and Genetics

Record: 141

08/01/2020

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for ACOR.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 142

07/31/2020

Industry Report

Pages: 22

Neurology Prescription Sales Tracker -- Week Ending 7/24/20

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 143

07/21/2020

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for ACOR.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 144

07/14/2020

Daily Note

Pages: 30

Eye of the Storm? 2Q20 Commercial Biotech Preview

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 145

07/11/2020

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for ACOR.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 146

07/06/2020

Industry Report

Pages: 20

Neurology Prescription Sales Tracker - Week Ending 6/26/20

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 147

07/01/2020

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for ACOR.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 148

06/21/2020

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for ACOR.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 149

06/12/2020

Industry Report

Pages: 19

Biotechnology: Neurology Prescription Sales Tracker -- Week Ending 6/5/20

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 150

06/11/2020

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for ACOR.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 151

06/05/2020

Industry Report

Pages: 18

Neurology Prescription Sales Tracker - Week Ending 5/29/20

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 152

06/03/2020

Company Report

Pages: 8

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 153

06/01/2020

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for ACOR.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 154

05/21/2020

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for ACOR.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 155

05/14/2020

Company Report

Pages: 8

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 156

05/11/2020

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for ACOR.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 157

05/11/2020

Company Report

Pages: 8

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 158

05/06/2020

Daily Note

Pages: 13

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Analyst: Research Department

Price: 50.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 159

05/06/2020

Company Report

Pages: 8

Inbrija Faces Seasonality, COVID-19 Headwinds; FY20 Guidance Withdrawn

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 160

05/06/2020

Company Report

Pages: 4

Revenue Disappoints as Pandemic Impact Hits; Reducing Target to $5; Reiterate Neutral

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party
// eof